Loading…
Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine
We report a case report of hyperleukocytosis, fever, hypotension, pulmonary and pericardial effusions, and acute kidney injury during initial treatment with azacitidine in a patient with AML‐MRC. Collectively, the symptomatology resembled differentiation syndrome. Azacitidine has been previously ass...
Saved in:
Published in: | European journal of haematology 2015-11, Vol.95 (5), p.484-485 |
---|---|
Main Authors: | , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
cited_by | cdi_FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83 |
---|---|
cites | cdi_FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83 |
container_end_page | 485 |
container_issue | 5 |
container_start_page | 484 |
container_title | European journal of haematology |
container_volume | 95 |
creator | Laufer, Christin B. Roberts, Owen |
description | We report a case report of hyperleukocytosis, fever, hypotension, pulmonary and pericardial effusions, and acute kidney injury during initial treatment with azacitidine in a patient with AML‐MRC. Collectively, the symptomatology resembled differentiation syndrome. Azacitidine has been previously associated with fever, peripheral edema, and hyperleukocytosis, but its side effect profile has never been described as similar to differentiation syndrome. The patient's deteriorating course quickly turned around after treatment with dexamethasone. This potential reaction, and potential treatment, is important for clinicians to be aware of. |
doi_str_mv | 10.1111/ejh.12598 |
format | article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1722927827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1722927827</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83</originalsourceid><addsrcrecordid>eNp1kL1OwzAURi0EoqUw8ALIIwxpbcd14hGVQkGVGIA5cuwb1SU_xXZUhacnkMLGXe5yvjMchC4pmdL-ZrDdTCmby_QIjakgJCKCyGM0JpKwiHNOR-jM-y0hhEmanKIRE5RwScQYvdzZogAHdbAq2KbGvquNayrAtsZKtwFw1UHZWINLaN-hsgqrIoDDwYEKVT_Eexs2WH0qbYM1toZzdFKo0sPF4U_Q2_3ydbGK1s8Pj4vbdaRjNk-jWBeaCxYzKRLBeJ5CrBQ1BISBmOl5bKgxmhtKhZqTXBFpEsF1LKjJ09Sk8QRdD96daz5a8CGrrNdQlqqGpvUZTRiTLElZ0qM3A6pd472DIts5WynXZZRk3w2zvmH207Bnrw7aNq_A_JG_0XpgNgB7W0L3vylbPq0G5RcgRXvl</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1722927827</pqid></control><display><type>article</type><title>Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine</title><source>Wiley-Blackwell Read & Publish Collection</source><creator>Laufer, Christin B. ; Roberts, Owen</creator><creatorcontrib>Laufer, Christin B. ; Roberts, Owen</creatorcontrib><description>We report a case report of hyperleukocytosis, fever, hypotension, pulmonary and pericardial effusions, and acute kidney injury during initial treatment with azacitidine in a patient with AML‐MRC. Collectively, the symptomatology resembled differentiation syndrome. Azacitidine has been previously associated with fever, peripheral edema, and hyperleukocytosis, but its side effect profile has never been described as similar to differentiation syndrome. The patient's deteriorating course quickly turned around after treatment with dexamethasone. This potential reaction, and potential treatment, is important for clinicians to be aware of.</description><identifier>ISSN: 0902-4441</identifier><identifier>EISSN: 1600-0609</identifier><identifier>DOI: 10.1111/ejh.12598</identifier><identifier>PMID: 26104906</identifier><language>eng</language><publisher>England</publisher><subject>Aged ; Azacitidine ; Azacitidine - administration & dosage ; Azacitidine - adverse effects ; Differentiation syndrome ; Female ; Fever - chemically induced ; Fever - drug therapy ; Fever - pathology ; Fever - physiopathology ; Humans ; Hypotension - chemically induced ; Hypotension - drug therapy ; Hypotension - pathology ; Hypotension - physiopathology ; Leukemia, Myeloid, Acute - drug therapy ; Leukemia, Myeloid, Acute - pathology ; Leukemia, Myeloid, Acute - physiopathology ; Pericardial Effusion - chemically induced ; Pericardial Effusion - drug therapy ; Pericardial Effusion - pathology ; Pericardial Effusion - physiopathology ; Syndrome</subject><ispartof>European journal of haematology, 2015-11, Vol.95 (5), p.484-485</ispartof><rights>2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd</rights><rights>2015 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83</citedby><cites>FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27922,27923</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/26104906$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Laufer, Christin B.</creatorcontrib><creatorcontrib>Roberts, Owen</creatorcontrib><title>Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine</title><title>European journal of haematology</title><addtitle>Eur J Haematol</addtitle><description>We report a case report of hyperleukocytosis, fever, hypotension, pulmonary and pericardial effusions, and acute kidney injury during initial treatment with azacitidine in a patient with AML‐MRC. Collectively, the symptomatology resembled differentiation syndrome. Azacitidine has been previously associated with fever, peripheral edema, and hyperleukocytosis, but its side effect profile has never been described as similar to differentiation syndrome. The patient's deteriorating course quickly turned around after treatment with dexamethasone. This potential reaction, and potential treatment, is important for clinicians to be aware of.</description><subject>Aged</subject><subject>Azacitidine</subject><subject>Azacitidine - administration & dosage</subject><subject>Azacitidine - adverse effects</subject><subject>Differentiation syndrome</subject><subject>Female</subject><subject>Fever - chemically induced</subject><subject>Fever - drug therapy</subject><subject>Fever - pathology</subject><subject>Fever - physiopathology</subject><subject>Humans</subject><subject>Hypotension - chemically induced</subject><subject>Hypotension - drug therapy</subject><subject>Hypotension - pathology</subject><subject>Hypotension - physiopathology</subject><subject>Leukemia, Myeloid, Acute - drug therapy</subject><subject>Leukemia, Myeloid, Acute - pathology</subject><subject>Leukemia, Myeloid, Acute - physiopathology</subject><subject>Pericardial Effusion - chemically induced</subject><subject>Pericardial Effusion - drug therapy</subject><subject>Pericardial Effusion - pathology</subject><subject>Pericardial Effusion - physiopathology</subject><subject>Syndrome</subject><issn>0902-4441</issn><issn>1600-0609</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><recordid>eNp1kL1OwzAURi0EoqUw8ALIIwxpbcd14hGVQkGVGIA5cuwb1SU_xXZUhacnkMLGXe5yvjMchC4pmdL-ZrDdTCmby_QIjakgJCKCyGM0JpKwiHNOR-jM-y0hhEmanKIRE5RwScQYvdzZogAHdbAq2KbGvquNayrAtsZKtwFw1UHZWINLaN-hsgqrIoDDwYEKVT_Eexs2WH0qbYM1toZzdFKo0sPF4U_Q2_3ydbGK1s8Pj4vbdaRjNk-jWBeaCxYzKRLBeJ5CrBQ1BISBmOl5bKgxmhtKhZqTXBFpEsF1LKjJ09Sk8QRdD96daz5a8CGrrNdQlqqGpvUZTRiTLElZ0qM3A6pd472DIts5WynXZZRk3w2zvmH207Bnrw7aNq_A_JG_0XpgNgB7W0L3vylbPq0G5RcgRXvl</recordid><startdate>201511</startdate><enddate>201511</enddate><creator>Laufer, Christin B.</creator><creator>Roberts, Owen</creator><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>201511</creationdate><title>Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine</title><author>Laufer, Christin B. ; Roberts, Owen</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Aged</topic><topic>Azacitidine</topic><topic>Azacitidine - administration & dosage</topic><topic>Azacitidine - adverse effects</topic><topic>Differentiation syndrome</topic><topic>Female</topic><topic>Fever - chemically induced</topic><topic>Fever - drug therapy</topic><topic>Fever - pathology</topic><topic>Fever - physiopathology</topic><topic>Humans</topic><topic>Hypotension - chemically induced</topic><topic>Hypotension - drug therapy</topic><topic>Hypotension - pathology</topic><topic>Hypotension - physiopathology</topic><topic>Leukemia, Myeloid, Acute - drug therapy</topic><topic>Leukemia, Myeloid, Acute - pathology</topic><topic>Leukemia, Myeloid, Acute - physiopathology</topic><topic>Pericardial Effusion - chemically induced</topic><topic>Pericardial Effusion - drug therapy</topic><topic>Pericardial Effusion - pathology</topic><topic>Pericardial Effusion - physiopathology</topic><topic>Syndrome</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Laufer, Christin B.</creatorcontrib><creatorcontrib>Roberts, Owen</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>European journal of haematology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Laufer, Christin B.</au><au>Roberts, Owen</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine</atitle><jtitle>European journal of haematology</jtitle><addtitle>Eur J Haematol</addtitle><date>2015-11</date><risdate>2015</risdate><volume>95</volume><issue>5</issue><spage>484</spage><epage>485</epage><pages>484-485</pages><issn>0902-4441</issn><eissn>1600-0609</eissn><abstract>We report a case report of hyperleukocytosis, fever, hypotension, pulmonary and pericardial effusions, and acute kidney injury during initial treatment with azacitidine in a patient with AML‐MRC. Collectively, the symptomatology resembled differentiation syndrome. Azacitidine has been previously associated with fever, peripheral edema, and hyperleukocytosis, but its side effect profile has never been described as similar to differentiation syndrome. The patient's deteriorating course quickly turned around after treatment with dexamethasone. This potential reaction, and potential treatment, is important for clinicians to be aware of.</abstract><cop>England</cop><pmid>26104906</pmid><doi>10.1111/ejh.12598</doi><tpages>2</tpages></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0902-4441 |
ispartof | European journal of haematology, 2015-11, Vol.95 (5), p.484-485 |
issn | 0902-4441 1600-0609 |
language | eng |
recordid | cdi_proquest_miscellaneous_1722927827 |
source | Wiley-Blackwell Read & Publish Collection |
subjects | Aged Azacitidine Azacitidine - administration & dosage Azacitidine - adverse effects Differentiation syndrome Female Fever - chemically induced Fever - drug therapy Fever - pathology Fever - physiopathology Humans Hypotension - chemically induced Hypotension - drug therapy Hypotension - pathology Hypotension - physiopathology Leukemia, Myeloid, Acute - drug therapy Leukemia, Myeloid, Acute - pathology Leukemia, Myeloid, Acute - physiopathology Pericardial Effusion - chemically induced Pericardial Effusion - drug therapy Pericardial Effusion - pathology Pericardial Effusion - physiopathology Syndrome |
title | Differentiation syndrome in acute myeloid leukemia after treatment with azacitidine |
url | http://sfxeu10.hosted.exlibrisgroup.com/loughborough?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-14T13%3A15%3A53IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Differentiation%20syndrome%20in%20acute%20myeloid%20leukemia%20after%20treatment%20with%20azacitidine&rft.jtitle=European%20journal%20of%20haematology&rft.au=Laufer,%20Christin%20B.&rft.date=2015-11&rft.volume=95&rft.issue=5&rft.spage=484&rft.epage=485&rft.pages=484-485&rft.issn=0902-4441&rft.eissn=1600-0609&rft_id=info:doi/10.1111/ejh.12598&rft_dat=%3Cproquest_cross%3E1722927827%3C/proquest_cross%3E%3Cgrp_id%3Ecdi_FETCH-LOGICAL-c3258-3cfc46232967624b8e3aa1d0e6de32c53d1ddc4d116a50ba09d764c361db88d83%3C/grp_id%3E%3Coa%3E%3C/oa%3E%3Curl%3E%3C/url%3E&rft_id=info:oai/&rft_pqid=1722927827&rft_id=info:pmid/26104906&rfr_iscdi=true |